Resiliency in Patients Undergoing Radical Cystectomy for Bladder Cancer
- Disease/Condition
- Bladder Cancer
- Study type
- Observational
- Primary sponsor
- University of Kansas Medical Center
- Location
- Kansas City, United States of America
- Phase
- N/A
- Start date
- Aug 19, 2020
- End date
- Aug 19, 2023
- Enrollment
- 74 participants
Change in resiliency as measured by the Connor-Davidson Resilience Scale (CD-RISC-25).,Change in quality of life in patients undergoing radical cystectomy as measured by the Functional Assessment of Cancer Therapy-Bladder-Cystectomy (FACT-Bl-Cys).,Change in quality of life in patients undergoing radical cystectomy as measured by the PROMIS-29.
This is a prospective cross-sectional survey-based study composed of both a retrospective
 chart review and 3-series patient survey. This study will help elicit potential areas
 throughout the perioperative course of radical cystectomy to improve patient resilience and
 quality of life, providing opportunity for future interventional studies.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT06337305
- Type
- Non-Device Trial
Access comprehensive clinical trial information for NCT06337305 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Kansas Medical Center and is currently Completed. The study focuses on Bladder Cancer. Target enrollment is 74 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.